(Q38687394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Clara de Andrés

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rebeca Pérez de Diego

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

5 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

101-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

TLR6: A novel member of an expanding toll-like receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like Receptors and Their Signaling Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Multiple sclerosis: Geoepidemiology, genetics and the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

HLA-DR15 haplotype and multiple sclerosis: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Environmental factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

HHV-6 infection in HIV-infected asymptomatic and AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Human herpesvirus 6 infection impairs Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Varicella zoster virus in progressive forms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Chronic helminth infections protect against allergic diseases by active regulatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Multiple sclerosis and viruses: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Cutting Edge: TREM-2 Attenuates Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Regulation of remyelination in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Effect of the innate immune response on development of Theiler's murine encephalomyelitis virus-induced demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Broad expression of Toll-like receptors in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Impaired toll-like receptor 8 signaling in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

The genetics of complex autoimmune diseases: non-MHC susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

A Decade of Research on TLR2 Discovering Its Pivotal Role in Glial Activation and Neuroinflammation in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Role of the MHC2TA gene in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

TLR-activated B cells suppress T cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Infections and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

IL-17-producing human peripheral regulatory T cells retain suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 2 controls expansion and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptors on regulatory T cells: expanding immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Genome-wide network analysis reveals the global properties of IFN-beta immediate transcriptional effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

New developments in Toll-like receptor targeted therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9665-5

Varicella zoster virus and relapsing remitting multiple sclerosis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.

1 reference

12 December 2020

Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS

1 reference

12 December 2020

Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy

1 reference

12 December 2020

Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look

1 reference

12 December 2020

Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta

1 reference

12 December 2020

Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection

1 reference

12 December 2020

DAMPening inflammation by modulating TLR signalling

1 reference

12 December 2020

Gene–environment interactions in multiple sclerosis: Innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway

1 reference

12 December 2020

Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis

1 reference

12 December 2020

Primary demyelination in Theiler's virus infection. An ultrastructural study

1 reference

12 December 2020

Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor

1 reference

12 December 2020

TLR signaling tailors innate immune responses in human microglia and astrocytes

1 reference

12 December 2020

Molecular mimicry and autoimmune disease

1 reference

12 December 2020

Lack of Chlamydia infection of the central nervous system in multiple sclerosis

1 reference

12 December 2020

Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis

1 reference

12 December 2020

Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice

1 reference

12 December 2020

A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity

1 reference

12 December 2020

Caspase-1 regulates the inflammatory process leading to autoimmune demyelination

1 reference

12 December 2020

10.1007/S12035-015-9665-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 March 2020

1051046798

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732593%20AND%20SRC:MED&resulttype=core&format=json